![Emergency Department Management of Patients Taking Direct Oral Anticoagulant Agents (Pharmacology CME) - Calculated Decisions - Emergency Department Emergency Department Management of Patients Taking Direct Oral Anticoagulant Agents (Pharmacology CME) - Calculated Decisions - Emergency Department](https://www.ebmedicine.net/media_library/images/MDCalc/HAS-BLED-Score-for-Major-Bleeding-Risk.png)
Emergency Department Management of Patients Taking Direct Oral Anticoagulant Agents (Pharmacology CME) - Calculated Decisions - Emergency Department
![Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor](https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2019/04/Table-1.jpg)
Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor
![Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X](https://pbs.twimg.com/media/DnYkH6WUYAABUzV.jpg)
Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X
![EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of](https://pbs.twimg.com/media/ElPNWqDWMAAsQB-.jpg)
EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of
![HAS-BLED Tool – What is the Real Risk of Bleeding in Anticoagulation? - American College of Cardiology HAS-BLED Tool – What is the Real Risk of Bleeding in Anticoagulation? - American College of Cardiology](https://www.acc.org/-/media/Non-Clinical/Migration-Content/Hot-Topics/AFib/HAS-BLED-Tool---What-is-the-Real-Risk-of-Bleeding-in-Anticoagulation/AFib_HotTopicSept_Table1.gif?la=en&hash=072703B80599DD5BEE810BBA2346020E0C1D8141)
HAS-BLED Tool – What is the Real Risk of Bleeding in Anticoagulation? - American College of Cardiology
![CHA2DS2-VASc and HAS-BLED integrated into EHR. Wow. Humility thy name is… – The Undiscovered Country CHA2DS2-VASc and HAS-BLED integrated into EHR. Wow. Humility thy name is… – The Undiscovered Country](https://ctlin.blog/wp-content/uploads/2019/01/cha2ds2vaschasbled-e1547658221355.png)
CHA2DS2-VASc and HAS-BLED integrated into EHR. Wow. Humility thy name is… – The Undiscovered Country
![Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology](https://www.ahajournals.org/cms/asset/8a3f7710-e5b1-4994-98bb-d139d599aba4/hae0021204930001.jpeg)
Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology
![The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study - ScienceDirect The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879820312875-gr7.jpg)
The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study - ScienceDirect
![Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? | Journal of the American College of Cardiology Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/dff69616-31e9-406e-898a-e026864c053d/gr2.jpg)
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? | Journal of the American College of Cardiology
![Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X](https://pbs.twimg.com/media/DnYkJP0UUAAJwMg.jpg)
Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X
CorConsult Rx - #Repost @ambcarerx ・・・ With Atrial Fibrillation, the largest concern is the risk of stroke, as blood pooling (stasis) can occur and cause a clot formation. Because of this, we
![COMORBIDITĂŢI ALE PACIENŢILOR V RSTNICI CU FIBRILAŢIE ATRIALĂ NON-VALVULARĂ ŞI DECIZIA ANTICOLAGULĂRII PERMANENTE CU ANTIVITAMINE K N PRACTICA MEDICALĂ CURENTĂ COMORBIDITĂŢI ALE PACIENŢILOR V RSTNICI CU FIBRILAŢIE ATRIALĂ NON-VALVULARĂ ŞI DECIZIA ANTICOLAGULĂRII PERMANENTE CU ANTIVITAMINE K N PRACTICA MEDICALĂ CURENTĂ](http://www.medicina-interna.ro/userfiles/Tabel1.jpg)
COMORBIDITĂŢI ALE PACIENŢILOR V RSTNICI CU FIBRILAŢIE ATRIALĂ NON-VALVULARĂ ŞI DECIZIA ANTICOLAGULĂRII PERMANENTE CU ANTIVITAMINE K N PRACTICA MEDICALĂ CURENTĂ
![Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions](https://www.ebmedicine.net/media_library/images/MDCalc/HAS-BLED.png)
Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions
![External Validation of the ORBIT Bleeding Score and the HAS-BLED Score in Nonvalvular Atrial Fibrillation Patients Using Direct Oral Anticoagulants (Asian Data from the DIRECT Registry) - ScienceDirect External Validation of the ORBIT Bleeding Score and the HAS-BLED Score in Nonvalvular Atrial Fibrillation Patients Using Direct Oral Anticoagulants (Asian Data from the DIRECT Registry) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914919307702-gr1.jpg)
External Validation of the ORBIT Bleeding Score and the HAS-BLED Score in Nonvalvular Atrial Fibrillation Patients Using Direct Oral Anticoagulants (Asian Data from the DIRECT Registry) - ScienceDirect
![Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions](https://www.ebmedicine.net/media_library/images/MDCalc/CHA2DS2.png)